Navigation Links
OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons
Date:5/16/2013

JACKSONVILLE, Florida, May 16, 2013 /PRNewswire/ --

OrthoView PSL will allow individual surgeons in private practice in the U.S. to access the widely-used OrthoView digital templating software via the Cloud and requires just a PC and Internet connection to get started.

OrthoView, the leading independent provider of digital pre-operative planning software for over 10 years, is dedicated to enabling orthopaedic surgeons in hospitals and private practices to template with digital x-ray images, when printed film is unavailable. Over 5,000 orthopaedic surgeons in the U.S. are now templating with OrthoView, and the software is installed worldwide in over 1,850 hospitals and clinics.

OrthoView PSL is the latest offering from the developers of OrthoView - and, for the first time, provides orthopaedic surgeons with their own subscription-based OrthoView templating solution. Now, individual orthopaedic surgeons can make the decision to start creating their pre-operative plans with OrthoView, simply download the solution and start templating with digital images within a matter of hours.

Currently only available to orthopaedic surgeons in private practice in the U.S., OrthoView PSL is one of a range of purchase and licensing options available from OrthoView, based in Jacksonville, FL. Chief Operating Officer, William Peterson , explains, "OrthoView PSL is a direct response to the frustration expressed by many surgeons who want to move into the 21st century and plan their surgeries with digital x-rays, but who do not have access to a digital templating solution.  For many, OrthoView PSL will be a stepping-stone to an OrthoView solution with full PACS connectivity and facility-wide licensing options."

Unlike other OrthoView licensing options, OrthoView PSL (Private User License) is a single-user license without PACS connectivity. Digital x-ray images are imported into the solution from the surgeon's computer or a DICOM CD and the resulting plan can be printed or saved along with the images.

OrthoView PSL Subscriptions start from one month and can be purchased by registering your details at http://connect.orthoview.com/psl-overview/.

About OrthoView

OrthoView is the most widely used independent digital templating solution, now available in over 60 countries worldwide and estimated to be used by over 10,000 orthopaedic surgeons. OrthoView is a focused, pre-operative planning solution for orthopaedics that incorporates on-screen measuring tools and patented wizards, designed to improve planning speed and accuracy. Incorporating a comprehensive library of digital templates from over 60 orthopaedic implant manufacturers, OrthoView offers pre-operative planning and templating for joint replacement surgery and fracture management, as well as specialist modules for pediatric assessment, limb deformity correction and spinal measurements. For more information, visit http://www.orthoview.com or call 1-800-318-0923.


'/>"/>
SOURCE OrthoView
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Horizon Blue ... affirmed the company’s credit rating of “A” and its outlook as “stable.” At the ... capital reserves, which have fallen in recent years, dip below “capital adequacy” thresholds required ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on ... or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, ...
Breaking Medicine News(10 mins):